Monkeypox antiviral drug put to the test in trial

United States News News

Monkeypox antiviral drug put to the test in trial
United States Latest News,United States Headlines
  • 📰 BBCLondonNews
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 51%

Researchers hope the drug can help accelerate recovery from the virus.

It is caused by the monkeypox virus, a member of the same family of viruses as smallpox, although much less severe.

Harun Tulunay, 35, from London, was hospitalised with a severe case of monkeypox which included a large lesion on his nose. He was treated with tecovirimat. "This study will help patients who are not in hospital to understand how tecovirimat works, what they can expect, and the time frame of the recovery process.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BBCLondonNews /  🏆 115. in UK

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Leeds bowlers set trap to catch 'disrespectful' teenagers after destruction of memorial benchLeeds bowlers set trap to catch 'disrespectful' teenagers after destruction of memorial benchHarehills Park and Bowling Club said they had seen an “unprecedented level” of theft and destroyed property in the last eight months
Read more »

Nottingham chosen to be part of cycling prescription trialNottingham chosen to be part of cycling prescription trialNottingham is one of 11 local authority areas chosen to be part of the trial.
Read more »

Dad cries as he's cleared in court after neighbour died from punchDad cries as he's cleared in court after neighbour died from punchArthur Cabourn contested the case at trial
Read more »

Covid-19: Free lateral flow testing ends in Northern IrelandCovid-19: Free lateral flow testing ends in Northern IrelandHealth staff and those eligible for new Covid treatments will still have access to free tests.
Read more »



Render Time: 2025-03-04 09:11:57